Article
Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia.
JAMA - 15 Jan 2014
Steele Anna M, Shields Beverley M, Wensley Kirsty J, Colclough Kevin, Ellard Sian, Hattersley Andrew T
Abstract excerpt
IMPORTANCE: Glycemic targets in diabetes have been developed to minimize complication risk. Patients with heterozygous, inactivating glucokinase (GCK) mutations have mild fasting hyperglycemia from birth, resulting in an elevated glycated hemoglobin (HbA1c) level that mimics recommended levels fo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
